QUALIGEN THERAPEUTICS INC filings

SEC filings by QUALIGEN THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2022-05-27ALPHA CAPITAL ANSTALTQualigen Therapeutics, Inc.3,525,04210.0%EDGAR
SC 13G/A2022-01-05SABBY MANAGEMENT, LLCQualigen Therapeutics, Inc.00.0%EDGAR
SC 13G2021-12-06SABBY MANAGEMENT, LLCQualigen Therapeutics, Inc.1,960,0005.6%EDGAR
SC 13G2020-06-01Greenblock Capital, LLCQualigen Therapeutics, Inc.811,4316.5%EDGAR
SC 13G2020-06-01SEKISUI DIAGNOSTICS, LLCQualigen Therapeutics, Inc.1,980,23315.8%EDGAR
SC 13G2020-05-28ALPHA CAPITAL ANSTALTQualigen Therapeutics, Inc.1,240,0889.9%EDGAR
SC 13G/A2020-02-14Alyeska Investment Group, L.P.RITTER PHARMACEUTICALS INC425,0004.2%EDGAR
SC 13G/A2020-01-29Step Michael DRITTER PHARMACEUTICALS INC128,7570.7%EDGAR
SC 13G/A2020-01-28Stonehenge Partners LLCRITTER PHARMACEUTICALS INC119,1970.6%EDGAR
SC 13G/A2019-02-14Alyeska Investment Group, L.P.RITTER PHARMACEUTICALS INC572,89010.0%EDGAR
SC 13G/A2019-02-13BAKER BROS. ADVISORS LPRITTER PHARMACEUTICALS INC286,4995.0%EDGAR
SC 13G/A2018-02-14Alyeska Investment Group, L.P.RITTER PHARMACEUTICALS INC4,999,37110.0%EDGAR
SC 13G2018-02-13BAKER BROS. ADVISORS LPRITTER PHARMACEUTICALS INC2,800,0005.7%EDGAR
SC 13G/A2018-01-09SABBY MANAGEMENT, LLCRITTER PHARMACEUTICALS INC2,470,3755.0%EDGAR
SC 13D/A2017-11-28Javelin Venture Partners GP, LLCRITTER PHARMACEUTICALS INC7,131,02814.4%EDGAR
SC 13D/A2017-10-31Javelin Venture Partners GP, LLCRITTER PHARMACEUTICALS INC12,131,02822.2%EDGAR
SC 13G2017-10-03SABBY MANAGEMENT, LLCRITTER PHARMACEUTICALS INC4,900,0009.9%EDGAR
SC 13G/A2017-02-15Step Michael DRITTER PHARMACEUTICALS INC948,8347.6%EDGAR
SC 13G/A2017-02-15Stonehenge Partners LLCRITTER PHARMACEUTICALS INC817,2717.0%EDGAR
SC 13G/A2017-02-14Knoll Capital Management, LPRITTER PHARMACEUTICALS INC952,4348.2%EDGAR